A  A  A   Print
FDA-Approved Drugs

FDA-Approved Drugs

The following drugs have been approved since the year 2000 for the treatment of multiple myeloma:

Revlimid (lenalidomide)

FDA approved for multiple myeloma June 2006

Lenalidomide, taken daily as a pill, is approved for use in patients with multiple myeloma who have had at least one prior treatment. The precise way in which the drug works is unclear, but it appears to boost the immune system and to prevent the development of new blood vessels that tumors need to grow. This drug causes severe, life-threatening birth defects or death to an unborn child and is only available under strict guidelines. To get lenalidomide, you must be registered in the RevAssist program. Your healthcare provider will explain the program to you and have you sign an agreement form. You will only receive up to a 28 day supply of the medicine at one time. You will need a new prescription for each refill.

Thalomid (thalidomide)

FDA approved for multiple myeloma May 2006

Thalidomide, taken daily as a pill, is approved for use in patients newly diagnosed with multiple myeloma. The precise way in which it works is unclear, but it appears to boost the immune system and to prevent the development of new blood vessels that tumors need to grow. This drug causes severe, life-threatening birth defects or death to an unborn child and is only available under strict guidelines. Both women and men must commit to strict guidelines when receiving thalidomide. To receive thalidomide, you, your physician, and your pharmacy must be registered in the System for Thalidomide Education and Prescribing Safety (STEPS) Program. You may only receive up to a 28-day supply of thalidomide at a time, and you will need a new prescription for each refill. Your prescription must be filled within seven days of your doctor's office visit.

Velcade (bortezomib)

FDA approved May 2003

This drug, given as an injection, approved for the treatment of patients with multiple myeloma. Velcade is the first in a new class of anticancer agents known as proteasome inhibitors.

Zometa (zoledronate)

FDA approved February 2002

This drug, given as an IV injection, helps slow the action of cells called osteoclasts, which break down bone. It is approved for use in people with multiple myeloma.

This drug also reduces the release and breakdown of calcium from bone. It is used when you have a high amount of calcium in your blood to lower the blood calcium levels. High blood calcium levels can make you confused and tired and cause stomach pain and muscle weakness. Zoledronic acid helps to relieve these symptoms.

 

 
Related Items

The third-party content provided in the Health Library of phoebeputney.com is for informational purposes only and is not designed to diagnose or treat a health problem or disease, or replace the professional medical advice you receive from your physician. If you or your child has or suspect you may have a health problem, please consult your primary care physician. If you or your child may have a medical emergency, call your doctor or 911 or other emergency health care provider immediately in the United States or the appropriate health agency of your country. For more information regarding site usage, please visit: Privacy Information, Terms of Use or Disclaimer.

Follow us online:

© 2014 Phoebe Putney Health System  |  417 Third Avenue, Albany, Georgia 31701  |  Telephone 877.312.1167

Phoebe Putney Health System is a network of hospitals, family medicine clinics, rehab facilities, auxiliary services, and medical education training facilities. Founded in 1911,
Phoebe Putney Memorial Hospital (the flagship hospital) is one of Georgia's largest comprehensive regional medical centers. From the beginning, Phoebe's mission and vision
has been to bring the finest medical talent and technology to the citizens of Southwest Georgia, and to serve all citizens of the community regardless of ability to pay.